Neurobiology of Disease Urokinase-Type Plasminogen Activator Promotes Dendritic Spine Recovery and Improves Neurological Outcome Following Ischemic Stroke

نویسندگان

  • Fang Wu
  • Marcela Catano
  • Ramiro Echeverry
  • Enrique Torre
  • Woldeab B. Haile
  • Jie An
  • Changhua Chen
  • Lihong Cheng
  • Andrew Nicholson
  • Frank C. Tong
  • Jaekeun Park
  • Manuel Yepes
چکیده

Fang Wu,1* Marcela Catano,1* Ramiro Echeverry,1* Enrique Torre,1 Woldeab B. Haile,1 Jie An,1,2 Changhua Chen,1 Lihong Cheng,1 Andrew Nicholson,3 Frank C. Tong,4 Jaekeun Park,5 and X Manuel Yepes1,6 1Department of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322, 2Department of Pharmacology, Shandong University School of Medicine, 250100 Jinan, China, 3Department of Radiology and Imaging Sciences and 4Departments of Radiology and Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322, 5Wallace H. Coulter Department of Biomedical Engineering, Emory University, Atlanta, Georgia 30322, and 6Department of Neurology, Veterans Affairs Medical Center, Atlanta, Georgia 30349

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke.

Spines are dendritic protrusions that receive most of the excitatory input in the brain. Early after the onset of cerebral ischemia dendritic spines in the peri-infarct cortex are replaced by areas of focal swelling, and their re-emergence from these varicosities is associated with neurological recovery after acute ischemic stroke (AIS). Urokinase-type plasminogen activator (uPA) is a serine pr...

متن کامل

The Outcome of Treatment With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Background: Thrombolytic therapy is the recommended treatment of acute ischemic stroke. It is crucial to evaluate the treatment results with recombinant Tissue Plasminogen Activator (r-TPA) in patients with acute stroke. Objectives: This study aimed to evaluate treatment outcomes with r-TPA in patients with acute stroke in a referral stroke center in Iran. Materials & Methods: In this retrosp...

متن کامل

Urokinase-type plasminogen activator promotes synaptic repair in the ischemic brain

The central nervous system has a very high energy requirement. Accordingly, despite representing only 2% of the body’s mass, the brain uses 20% of the total oxygen consumption. Importantly, because most of this energy is used to maintain synaptic activity, even a mild decrease in its supply to the brain has deleterious implications for synaptic function. For example, only one minute of interrup...

متن کامل

Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke.

BACKGROUND AND PURPOSE The capacity of an intravenous infusion of double-stranded tissue-type plasminogen activator to salvage neurological functions in a rat model of thromboembolic stroke was studied. METHODS The model of thromboembolic stroke was induced by the intracarotid injection of 2-hour-old homologous blood clots to rats. Neurological functions were scored on a 5-point scale 48 hour...

متن کامل

Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) promote neurorepair in the ischemic brain

Despite the fact that ischemic stroke has been considered a leading cause of mortality in the world, recent advances in our understanding of the pathophysiological mechanisms underlying the ischemic injury and the treatment of acute ischemic stroke patients have led to a sharp decrease in the number of stroke deaths. However, this decrease in stroke mortality has also led to an increase in the ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014